Jikei Kashiwa Hospital, 
163-1 Kashiwashita, Kashiwa-shi, Chiba 277- 8567
Japan						                            
                            
						
 Research Article
												Use of Localization and Activity of Thymidine Phosphorylase in
Human Gynecological Tumors for Predicting Sensitivity to Pyrimidine
Antimetabolite Therapy: An Observational Study 						
Author(s): Yuzuru Kotake, Toru Sasaki, Hiroshi Sasaki, Minoru Akiyama, Kazunori Ochiai, Shinji Sato, Akira Yajima, Kazuo Hasegawa, Michiaki Yakushiji, Shinichi Tsuchiya and Kiichiro NodaYuzuru Kotake, Toru Sasaki, Hiroshi Sasaki, Minoru Akiyama, Kazunori Ochiai, Shinji Sato, Akira Yajima, Kazuo Hasegawa, Michiaki Yakushiji, Shinichi Tsuchiya and Kiichiro Noda             
						
												
				 Background:  Thymidine phosphorylase (dThdPase) is the rate-limiting enzyme in the conversion of 5 ′ -deoxy- 5-fluorouridine  (5 ′ -dFUrd),  an  intermediate  metabolite  of  capecitabine  (Xeloda ® ),  to  5-fluorouracil  (5-FU).  We  investigated  the  correlation  between  dThdPase  activity  and  immunohistochemical  staining  in  gynecological  carcinoma and adjacent normal tissues. We hypothesize that the differential dThdPase activity between tumors and  adjacent tissue is predictive of response to treatment with pyrimidine antimetabolites.
Methods:  In 45 samples of carcinoma tissue and 35 of adjacent normal tissue from 45 patients, we measured  dThdPase activity as well as immunoreactivity using an anti-dThdPase monoclonal antibody and macrophage and  histiocyte-specific antibodies.
Results:  d.. Read More»
				  
												DOI:
												 10.4172/2157-7099.1000121 
																	  
Journal of Cytology & Histology received 2476 citations as per Google Scholar report